Literature DB >> 20495323

[A case of gastric large cell neuroendocrine carcinoma (LCNEC) for whom chemotherapy of CDDP+CPT-11 proved very effective].

Yasushi Kirii1, Chihiro Ichikawa, Masatake Miyamoto, Motoyuki Hata, Junichi Miyairi, Hiroyuki Takagi, Mana Fukushima, Hiroyoshi Ota.   

Abstract

Large cell neuroendocrine carcinoma(LCNEC)is a relatively new category with biological behavior similar to small cell carcinoma. Thus, it is reportedly well treated by the same chemotherapy as for small cell carcinoma. We experienced a case of gastric large cell neuroendocrine carcinoma, treated very effectively by CDDP+CPT-11.60 mg/m(2) of CDDP was administered on day 1, and 60 mg/m(2) of CPT-11 on day 1, 8 and 15. An intermission after administration for 14 days made for one course. Four courses were carried out. A complete response was obtained for a primary gastric lesion and liver metastasis, and a partial response was obtained for lymph node metastases. So far it has showed no change for 6 months after chemotherapy. Both CDDP and CPT-11 are key drugs in the chemotherapy for common gastric cancer, and it is sometimes difficult to distinguish large cell neuroendocrine carcinoma from poorly-differentiated gastric cancer. We found this combination chemotherapy is a suitable regimen for the assumed existence of large cell neuroendocrine carcinoma at the gastric lesion.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20495323

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  3 in total

1.  Gastric adenocarcinoma? Looks similar but behaves differently!

Authors:  Tarun Rustagi; Mridula Rai; Todd J Alekshun
Journal:  J Gastrointest Cancer       Date:  2012-03

2.  Oligometastatic Large Cell Neuroendocrine Carcinoma of the Brain Without Radiologically Detected Primary.

Authors:  Moyosore Suleiman; Michael Mullane
Journal:  World J Oncol       Date:  2014-06-25

3.  Endocrine carcinoma of the stomach: clinicopathological analysis of 27 surgically treated cases in a single institute.

Authors:  Takeshi Kubota; Shigekazu Ohyama; Naoki Hiki; Souya Nunobe; Noriko Yamamoto; Toshiharu Yamaguchi
Journal:  Gastric Cancer       Date:  2012-01-18       Impact factor: 7.370

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.